Targeting shared molecular etiologies to accelerate drug development for rare diseases.
Zanello G, Garrido-Estepa M, Crespo A, O'Connor D, Nabbout R, Waters C, Hall A, Taglialatela M, Chan CH, Pearce DA, Dooms M, Brooks PJ.
Zanello G, et al. Among authors: dooms m.
EMBO Mol Med. 2023 Jul 10;15(7):e17159. doi: 10.15252/emmm.202217159. Epub 2023 Jun 27.
EMBO Mol Med. 2023.
PMID: 37366158
Free PMC article.
Review.